ArticleMolecular biology reports2026
Epidemiological, clinical, and molecular studies on nail disorders in the human population of Punjab, Pakistan.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNail disorders in Pakistan are an underestimated burden, and no population-based molecular data on nail disorders in Punjab have been provided previously. The study aims to establish prevalence, clinical presentation, risk factors and genetic structure of nail disorders in ten districts. Methods and.
resultsA cross-sectional survey (20,222,024) involved the recruitment of 1,240 affected participants and 480 controls. Diagnostics consisted of mycological culture, dermoscopy, histopathology, targeted NGS (NailGenome-94v2), and pharmacogenomic (CYP2C19, CYP3A4, ABCB1). The overall prevalence was 98.4/1,000 with a southern hotspot: Sadiqabad (127.6/1,000), Rahim Yar Khan (119.2/1,000) and Bahawalpur (112.8/1,000). Severe onychomycosis was predicted by agricultural occupation (aOR 2.14), pesticide exposure (aOR 1.98), and living in the south (aOR 2.87). In 17 Seraiki-speaking families, a novel FZD6 c.1757G > A (p.Arg586Gln) variant was identified, with shared haplotype evidence suggesting a possible founder effect; however, this interpretation requires confirmation in larger population-based and functional studies. The prevalence of a CYP2C19 poor metabolizer was 12.4% and was independently related to itraconazole hepatotoxicity (aOR 4.12).
conclusionsThe high burden of nail disease in Punjab appears to reflect occupational exposures, delayed diagnosis, and possible enrichment of hereditary nail-disorder variants in southern districts. In this group, pretreatment CYP2C19 screening would be justified to use systemic itraconazole. CLINICAL
trial registrationClinical trial number: not applicable.
Indexed as
Identifiers
42461476What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.